|
1
|
Ferro A, Peleteiro B, Malvezzi M, Bosetti
C, Bertuccio P, Levi F, Negri E, La Vecchia C and Lunet N:
Worldwide trends in gastric cancer mortality (1980–2011), with
predictions to 2015, and incidence by subtype. Eur J Cancer.
50:1330–1344. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bertuccio P, Chatenoud L, Levi F, Praud D,
Ferlay J, Negri E, Malvezzi M and La Vecchia C: Recent patterns in
gastric cancer: A global overview. Int J Cancer. 125:666–673. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Son T and Hyung WJ: Laparoscopic gastric
cancer surgery: Current evidence and future perspectives. World J
Gastroenterol. 22:727–735. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Xu W, Beeharry MK, Liu W, Yan M and Zhu Z:
Preoperative chemotherapy for gastric cancer: Personal
interventions and precision medicine. Biomed Res Int.
2016:39235852016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bhowmick NA, Neilson EG and Moses HL:
Stromal fibroblasts in cancer initiation and progression. Nature.
432:332–337. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Erez N, Truitt M, Olson P, Arron ST and
Hanahan D: Cancer-associated fibroblasts are activated in incipient
neoplasia to orchestrate tumor-promoting inflammation in an
NF-kappaB-dependent manner. Cancer Cell. 17:135–147. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Sugimoto H, Mundel TM, Kieran MW and
Kalluri R: Identification of fibroblast heterogeneity in the tumor
microenvironment. Cancer Biol Ther. 5:1640–1646. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lee KW, Yeo SY, Sung CO and Kim SH: Twist1
is a key regulator of cancer-associated fibroblasts. Cancer Res.
75:73–85. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Satoyoshi R, Kuriyama S, Aiba N, Yashiro M
and Tanaka M: Asporin activates coordinated invasion of scirrhous
gastric cancer and cancer-associated fibroblasts. Oncogene.
34:650–660. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wang X, Zhou Q, Yu Z, Wu X, Chen X, Li J,
Li C, Yan M, Zhu Z, Liu B, et al: Cancer-associated
fibroblast-derived Lumican promotes gastric cancer progression via
the integrin β1-FAK signaling pathway. Int J Cancer. 141:998–1010.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sugihara H, Ishimoto T, Yasuda T, Izumi D,
Eto K, Sawayama H, Miyake K, Kurashige J, Imamura Y, Hiyoshi Y, et
al: Cancer-associated fibroblast-derived CXCL12 causes tumor
progression in adenocarcinoma of the esophagogastric junction. Med
Oncol. 32:6182015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Matsumoto K and Nakamura T: Hepatocyte
growth factor and the Met system as a mediator of tumor-stromal
interactions. Int J Cancer. 119:477–483. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kwon Y, Smith BD, Zhou Y, Kaufman MD and
Godwin AK: Effective inhibition of c-MET-mediated signaling, growth
and migration of ovarian cancer cells is influenced by the ovarian
tissue microenvironment. Oncogene. 34:144–153. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Phan LM, Fuentes-Mattei E, Wu W,
Velazquez-Torres G, Sircar K, Wood CG, Hai T, Jimenez C, Cote GJ,
Ozsari L, et al: Hepatocyte growth factor/cMET pathway activation
enhances cancer hallmarks in adrenocortical carcinoma. Cancer Res.
75:4131–4142. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Grugan KD, Miller CG, Yao Y, Ohashi S,
Klein-Szanto AJ, Diehl JA, Herlyn M, Han M, Nakagawa H and Rustgi
AK: Fibroblast-secreted hepatocyte growth factor plays a functional
role in esophageal squamous cell carcinoma invasion. Proc Natl Acad
Sci USA. 107:11026–11031. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Jedeszko C, Victor BC, Podgorski I and
Sloane BF: Fibroblast hepatocyte growth factor promotes invasion of
human mammary ductal carcinoma in situ. Cancer Res. 69:9148–9155.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wu X, Chen X, Zhou Q, Li P, Yu B, Li J, Qu
Y, Yan J, Yu Y, Yan M, et al: Hepatocyte growth factor activates
tumor stromal fibroblasts to promote tumorigenesis in gastric
cancer. Cancer Lett. 335:128–135. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Jiang J, Liu W, Guo X, Zhang R, Zhi Q, Ji
J, Zhang J, Chen X, Li J, Zhang J, et al: IRX1 influences
peritoneal spreading and metastasis via inhibiting BDKRB2-dependent
neovascularization on gastric cancer. Oncogene. 30:4498–4508. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Carmeliet P and Jain RK: Angiogenesis in
cancer and other diseases. Nature. 407:249–257. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Liu J, Huang J, Yao WY, Ben QW, Chen DF,
He XY, Li L and Yuan YZ: The origins of vacularization in tumors.
Front Biosci. 17:2559–2565. 2012. View
Article : Google Scholar
|
|
21
|
Zhang J, Qiao L, Liang N, Xie J, Luo H,
Deng G and Zhang J: Vasculogenic mimicry and tumor metastasis.
JBUON. 21:533–541. 2016.PubMed/NCBI
|
|
22
|
Guo Q, Yuan Y, Jin Z, Xu T, Gao Y, Wei H,
Li C, Hou W and Hua B: Association between tumor vasculogenic
mimicry and the poor prognosis of gastric cancer in China: An
updated systematic review and meta-analysis. Biomed Res Int.
2016:24086452016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Folkman J: Can mosaic tumor vessels
facilitate molecular diagnosis of cancer? Proc Natl Acad Sci USA.
98:398–400. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
di Tomaso E, Capen D, Haskell A, Hart J,
Logie JJ, Jain RK, McDonald DM, Jones R and Munn LL: Mosaic tumor
vessels: Cellular basis and ultrastructure of focal regions lacking
endothelial cell markers. Cancer Res. 65:5740–5749. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Chang YS, di Tomaso E, McDonald DM, Jones
R, Jain RK and Munn LL: Mosaic blood vessels in tumors: Frequency
of cancer cells in contact with flowing blood. Proc Natl Acad Sci
USA. 97:14608–14613. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Xu D, Matsuo Y, Ma J, Koide S, Ochi N,
Yasuda A, Funahashi H, Okada Y and Takeyama H: Cancer cell-derived
IL-1alpha promotes HGF secretion by stromal cells and enhances
metastatic potential in pancreatic cancer cells. J Surg Oncol.
102:469–477. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Lirdprapamongkol K, Chiablaem K, Sila-Asna
M, Surarit R, Bunyaratvej A and Svasti J: Exploring stemness gene
expression and vasculogenic mimicry capacity in well-and
poorly-differentiated hepatocellular carcinoma cell lines. Biochem
Biophys Res Commun. 422:429–435. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zang M, Zhang Y, Zhang B, Hu L, Li J, Fan
Z, Wang H, Su L, Zhu Z, Li C, et al: CEACAM6 promotes tumor
angiogenesis and vasculogenic mimicry in gastric cancer via FAK
signaling. Biochim Biophys Acta. 1852:1020–1028. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Li P, Shan JX, Chen XH, Zhang D, Su LP,
Huang XY, Yu BQ, Zhi QM, Li CL, Wang YQ, et al: Epigenetic
silencing of microRNA-149 in cancer-associated fibroblasts mediates
prostaglandin E2/interleukin-6 signaling in the tumor
microenvironment. Cell Res. 25:588–603. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhu CC, Chen C, Xu ZQ, Zhao JK, Ou BC, Sun
J, Zheng MH, Zong YP and Lu AG: CCR6 promotes tumor angiogenesis
via the AKT/NF-kappaB/VEGF pathway in colorectal cancer. Biochim
Biophy Acta. 1864:387–397. 2018. View Article : Google Scholar
|
|
31
|
Gao LM, Wang F, Zheng Y, Fu ZZ, Zheng L
and Chen LL: Roles of fibroblast activation protein and hepatocyte
growth factor expressions in angiogenesis and metastasis of gastric
cancer. Pathol Oncol Res. 2017. View Article : Google Scholar
|
|
32
|
Ma TH, Gao CC, Xie R, Yang XZ, Dai WJ,
Zhang JL, Yan W and Wu SN: Predictive values of FAP and HGF for
tumor angiogenesis and metastasis in colorectal cancer. Neoplasma.
64:880–886. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Liu X, Wang JH, Li S, Li LL, Huang M,
Zhang YH, Liu Y, Yang YT, Ding R and Ke YQ: Histone deacetylase 3
expression correlates with vasculogenic mimicry through the
phosphoinositide3-kinase/ERK-MMP-laminin5gamma2 signaling pathway.
Cancer Sci. 106:857–866. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Chen LX, He YJ, Zhao SZ, Wu JG, Wang JT,
Zhu LM, Lin TT, Sun BC and Li XR: Inhibition of tumor growth and
vasculogenic mimicry by curcumin through down-regulation of the
EphA2/PI3K/MMP pathway in a murine choroidal melanoma model. Cancer
Biol Ther. 11:229–235. 2014. View Article : Google Scholar
|
|
35
|
Ruf W, Seftor EA, Petrovan RJ, Weiss RM,
Gruman LM, Margaryan NV, Seftor RE, Miyagi Y and Hendrix MJ:
Differential role of tissue factor pathway inhibitors 1 and 2 in
melanoma vasculogenic mimicry. Cancer Res. 63:5381–5389.
2003.PubMed/NCBI
|
|
36
|
Du J, Sun B, Zhao X, Gu Q, Dong X, Mo J,
Sun T, Wang J, Sun R and Liu Y: Hypoxia promotes vasculogenic
mimicry formation by inducing epithelial-mesenchymal transition in
ovarian carcinoma. Gynecol Oncol. 133:575–583. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Liu Q, Qiao L, Liang N, Xie J and Zhang J,
Deng G, Luo H and Zhang J: The relationship between vasculogenic
mimicry and epithelial-mesenchymal transitions. J Cell Mol Med.
20:1761–1769. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Zhang H, Deng T, Liu R, Bai M, Zhou L,
Wang X, Li S, Wang X, Yang H, Li J, et al: Exosome-delivered EGFR
regulates liver microenvironment to promote gastric cancer liver
metastasis. Nat Commun. 8:150162017. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Hao NB, Tang B, Wang GZ, Xie R, Hu CJ,
Wang SM, Wu YY, Liu E, Xie X and Yang SM: Hepatocyte growth factor
(HGF) upregulates heparanase expression via the PI3K/Akt/NF-κB
signaling pathway for gastric cancer metastasis. Cancer Lett.
361:57–66. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Hanahan D and Weinberg RA: Hallmarks of
cancer: The next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Borcoman E and Le Tourneau C:
Pembrolizumab in cervical cancer: Latest evidence and clinical
usefulness. Ther Adv Med Oncol. 9:431–439. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Fuchs CS, Marshall J and Barrueco J:
Randomized, controlled trial of irinotecan plus infusional, bolus,
or oral fluoropyrimidines in first-line treatment of metastatic
colorectal cancer: Updated results from the BICC-C study. J Clin
Oncol. 26:689–690. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Ye W: The Complexity of translating
anti-angiogenesis therapy from basic science to the clinic. Dev
Cell. 37:114–125. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Zhang S, Zhang D and Sun B: Vasculogenic
mimicry: Current status and future prospects. Cancer Lett.
254:157–164. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Jin J, Yuan F, Shen MQ, Feng YF and He QL:
Vascular endothelial growth factor regulates primate
choroid-retinal endothelial cell proliferation and tube formation
through PI3K/Akt and MEK/ERK dependent signaling. Mol Cell Biochem.
381:267–272. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Kim GD: Kaempferol inhibits angiogenesis
by suppressing HIF-1α and VEGFR2 activation via ERK/p38 MAPK and
PI3K/Akt/mTOR signaling pathways in endothelial cells. Prev Nutr
Food Sci. 22:320–326. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Huang B, Xiao E and Huang M: MEK/ERK
pathway is positively involved in hypoxia-induced vasculogenic
mimicry formation in hepatocellular carcinoma which is regulated
negatively by protein kinase A. Med Oncol. 32:4082015. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Chiablaem K, Lirdprapamongkol K,
Keeratichamroen S, Surarit R and Svasti J: Curcumin suppresses
vasculogenic mimicry capacity of hepatocellular carcinoma cells
through STAT3 and PI3K/AKT inhibition. Anticancer Res.
34:1857–1864. 2014.PubMed/NCBI
|
|
49
|
Williamson SC, Metcalf RL, Trapani F,
Mohan S, Antonello J, Abbott B, Leong HS, Chester CPE, Simms N,
Polanski R, et al: Vasculogenic mimicry in small cell lung cancer.
Nat Commun. 7:133222016. View Article : Google Scholar : PubMed/NCBI
|
